Teligent Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2021 to a ratio of 3.91, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2021. Average receivable collection period, for the Teligent Inc in Jun 30 2021 quarter, has decreased to 93 days, compared to 94 days, in the Mar 31 2021 quarter.

If we take a look into Healthcare sector 482 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2021 from 2266 to 3218.

What is Receivable Turnover Ratio?
What is Teligent Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TLGT Receivables Turnover Ratio	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter
Y / Y Receivable Change	-27.34 %	16.41 %	-44.75 %	-19.48 %	-30.16 %
Y / Y Revenue Change	-23.21 %	55.61 %	-37.77 %	-22.35 %	-25.93 %
Receivable Turnover Ratio (TTM)	3.91	3.87	3.65	3.49	3.53
TLGT's Total Ranking	# 3218	# 2266	# 3181	# 2265	# 3200
Accounts Receivable average collection period days	93	94	100	105	103
Seq. Receivable Change	-0.42 %	-12.13 %	-31.33 %	20.94 %	59.53 %
Seq. Revenue Change	-9.97 %	16.61 %	-30.7 %	5.54 %	82.44 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 174
Healthcare Sector	# 483
Overall Market	# 3218

Receivable Turnover Ratio Statistics
High	Average	Low
5.88	3.63	1.34
(Mar 31 2014)		(Dec 31 2015)

TLGT Company Profile • Back to TLGT Efficiency Comparisons • Compare TLGT Receivables Turnover Ratio to its Competitors

Financial Statements
Teligent Inc 's Accounts Receivable	$ 10 Millions	Visit TLGT's Balance sheet
Teligent Inc 's Sales TTM	$ 46 Millions	Visit TLGT's Income Statement
Sources of TLGT's Revenues		Visit TLGT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TLGT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TLGT's Growth Rates	TLGT's Roa	TLGT's Inventory Turnover Ratio	TLGT's Dividend Comparisons
TLGT's Profitability Ratios	TLGT's Roi	TLGT's Asset Turnover Ratio	TLGT's Dividend Growth
TLGT's Valuation Ratios	TLGT's Roe	TLGT's Financial Strength Ratios	TLGT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2021	Receivable at quarter ending Jun 30 2021
Escalon Medical Corp	12.76	$ 10.472 Millions	$ 0.821 Millions
Pulmatrix Inc	12.70	$ 10.016 Millions	$ 0.789 Millions
Eargo Inc	12.63	$ 85.495 Millions	$ 6.767 Millions
La Jolla Pharmaceutical Company	12.48	$ 70.219 Millions	$ 5.628 Millions
Emmaus Life Sciences Inc	12.37	$ 23.677 Millions	$ 1.914 Millions
Rockwell Medical inc	12.06	$ 61.054 Millions	$ 5.063 Millions
Cano Health Inc	11.93	$ 393.163 Millions	$ 32.958 Millions
Morphic Holding inc	11.91	$ 38.771 Millions	$ 3.256 Millions
Conformis inc	11.90	$ 103.001 Millions	$ 8.655 Millions
Clene Inc	11.82	$ 0.201 Millions	$ 0.017 Millions
Therapeutic Solutions International Inc	11.82	$ 0.074 Millions	$ 0.006 Millions
Integrated Biopharma Inc	11.76	$ 63.559 Millions	$ 5.406 Millions
Alpha Pro Tech Ltd	11.73	$ 100.013 Millions	$ 8.527 Millions
Kushco Holdings Inc	11.69	$ 114.640 Millions	$ 9.808 Millions
Chembio Diagnostics Inc	11.61	$ 35.686 Millions	$ 3.073 Millions
Cidara Therapeutics Inc	11.55	$ 41.416 Millions	$ 3.586 Millions
Aim Immunotech Inc	11.48	$ 21.870 Millions	$ 1.906 Millions
Strongbridge Biopharma plc	11.46	$ 34.721 Millions	$ 3.031 Millions
Teladoc Health Inc	11.43	$ 1,486.656 Millions	$ 130.121 Millions
Esperion Therapeutics Inc	11.37	$ 62.108 Millions	$ 5.464 Millions
Scienture Holdings Inc	11.28	$ 13.278 Millions	$ 1.177 Millions
Vaso Corporation	11.28	$ 68.877 Millions	$ 6.108 Millions
Personalis Inc	11.16	$ 82.543 Millions	$ 7.396 Millions
Allied Healthcare Products inc	11.06	$ 36.278 Millions	$ 3.281 Millions
Lensar Inc	11.05	$ 30.394 Millions	$ 2.750 Millions
Ayala Pharmaceuticals Inc	10.88	$ 3.740 Millions	$ 0.344 Millions
Insulet Corporation	10.84	$ 995.600 Millions	$ 91.850 Millions
National Healthcare Corp	10.84	$ 1,024.582 Millions	$ 94.559 Millions
Mymetics Corporation	10.80	$ 0.623 Millions	$ 0.058 Millions
Utah Medical Products Inc	10.75	$ 46.057 Millions	$ 4.286 Millions

Date modified: 2026-08-29T17:31:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.